Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ifosfamide in Aggressive Meningeal Tumors
NCT00003292Phase 2Terminated
- Sponsor
- SWOG Cancer Research Network
- Start
- Jul 1998
- Primary completion
- Jan 2004
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 2, open-label, single-arm trial of ifosfamide in meningioma, hemangiopericytoma (HPC), fibrosarcoma and 3 more, sponsored by SWOG Cancer Research Network. Primary endpoints: Failure Free Survival, Overall Survival and 1 more. Started Jul 1998; status: terminated.
02
Drugs
ifosfamide
03
Conditions
meningiomahemangiopericytoma (HPC)fibrosarcomarhabdomyosarcoma (RMS)chondrosarcoma
Beyond the preview
Go deeper on NCT00003292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003292.